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The renal osteodystrophy pattern in Brazil and Uruguay: ent types of ROD in the diverse geographical areas [2]
An overview. has changed during the past two decades. Several condi-
Background. The prevalence of the types of renal osteodys- tions, including demographic and geographical factors,trophy (ROD) has changed in the last two decades. This study
different preventive measures, and therapeutic manage-evaluates the prevalence and determining factors of the types
ment of the dialyzed patients, in addition to no unifor-of ROD in two countries in South America.
Methods. Symptomatic patients who underwent bone biop- mity of the tools and diagnostic criteria, may contribute
sies for diagnostic purposes (1985 through 2001) were included to the outline of the ROD profile [3–7]. Although bone
in the study. In Brazil, a total of 2340 patients were reviewed, histomorphometry is the most reliable diagnostic method,93.1% on hemodialysis (HD), and 6.9% on continuous ambula-
in recent years, noninvasive methods of ROD diagnosistory peritoneal dialysis (CAPD). In Uruguay, 167 patients on
like iPTH and other biochemical markers to assess bonehemodialysis were included. Uncalcified bone samples were
analyzed in order to diagnose the different types of ROD. metabolism have elicited more rational criteria for the
Results. Comparing the 1980s to the 1990s, the prevalence need of bone biopsy [8].
of Brazilian patients with hyperparathyroid bone disease (HP)
The aims of this study were to analyze the prevalenceincreased from 32.3% to 44.0%, while Al overload decreased
of the different forms of ROD over time in symptomaticfrom 61.3% to 42.4%. A logistic regression analysis showed
that the main factors associated with HP included female gen- dialyzed patients who underwent bone biopsy in Brazil
der, age of less than 40 years, black patients, longer time on and Uruguay, and to identify risk factors that could be
dialysis, and absence of Al overload. In Uruguay, HP also associated with the pattern of ROD.increased over time from 31.8% to 70.5% (P  0.05), while
Al overload decreased from 42% to 27% (P  0.05).
Conclusion. A better control of Al overload may lead to a METHODSchange in histologic pattern, as evidenced by the increasing
prevalence of HP. A total of 2507 bone biopsies obtained over 16 years
in Brazil and Uruguay were studied. Bone analysis was
performed in three units (two in Sa˜o Paulo and one in
Renal osteodystrophy (ROD) in patients with chronic Rio de Janeiro, Brazil). In Brazil, a total of 2340 bone
renal failure on dialysis is a major long-term complica- biopsies from patients from various geographic areas
tion with high morbidity. Clinical and histologic forms (93.1% on HD and 6.9% on CAPD) were reviewed. The
of ROD comprise a wide spectrum that includes predom- majority of patients were white (53.8%), followed by
inant high turnover states, such as hyperparathyroid mullato (35.0%), and black (10.2%). There were 1120
bone disease (HP), mixed bone disease (MBD), low turn- female (47.9%) and 1220 male (52.1%), with a mean age
over osteomalacia (OM), and adynamic bone disease of 41.2  14.3 years, mean dialysis duration of 73.7 
(ABD). The mechanisms underlying the development 57.1 months. In Uruguay, we reviewed 167 bone biopsies
of these skeletal disorders are multifactorial and contro- from white patients on HD. Ninety-three patients were
versial, whereas the effects of aluminum (Al) overload female (55.7%) and 74 were male (44.3%), with a mean
have been well established [1]. The prevalence of differ- age of 54.0  13.0 years, and mean dialysis duration of
53.0  33.0 months.
Bone samples from the anterior iliac crest were ob-Key words: secondary hyperparathyroidism, aluminum, dialysis, bone
biopsy. tained and processed as previously described [2]. In-
formed consent was obtained in all patients. For iron 2003 by the International Society of Nephrology
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Table 1. Histologic diagnosis, number, and percentage according to country of origin and period of bone biopsy
Country Period years HP N % MBD N % OM N % ABD N %
Brazil P1 85–90 119 (32.3)a,b 61 (16.6)b 121 (32.9)a,b 67 (18.2)
P2 91–96 365 (42.6) 183 (21.4) 174 (20.3)c 134 (15.7)c
P3 97–01 491 (44.0) 267 (23.9) 130 (11.7) 228 (20.4)
Uruguay P1 85–90 21 (31.8)a,b 11 (16.6) 24 (36.6)a,b 10 (15)
P2 91–96 49 (58.3) 17 (20.2) 4 (4.5) 14 (17)
P3 97–00 12 (70.5) 0 (0) 0 (0) 5 (29.5)
a vs. P2 P  0.01
b vs. P3 P  0.05
c vs. P3 P  0.01
detection after 1998, Sa˜o Paulo units changed from aurin gender, white race, older age, short dialysis history, and
CAPD were associated with ABD (2, P  0.005). Bonetricarboxylic acid (Aluminon) to solochrome azurine
staining for detection of Al associated with Pearls stain- pain, arthralgia, and myalgia were the most frequent
symptoms in all patients. Fractures, muscle weakness,ing. Al overload was considered positive when Al surface
was greater than 30% of total trabecular surface. and myalgia were associated with OM (2, P  0.005).
The frequency of bone pain, arthralgia, and fracture werePatients were classified as predominantly HP, MBD,
OM, and ABD, according to histologic analysis. less commonly observed in ABD patients (2, P 0.005).
However, we did not find any differences in the fre-We analyzed the prevalence of the types of ROD
in three periods: 1985–1990 (P1), 1991–1996 (P2), and quency of fractures between ABD, HP, and MBD.
1997–2001 (P3). In Brazilian patients, we also analyzed
Data from Uruguaythe risk factors for each pattern of ROD. In Uruguay,
aluminum dialysis water was analyzed in P2 and P3 only. Similar to Brazil, HP increased over time from 31.8%
in P1 to 70.5% in P3 (P  0.05) (Table 1). MBD was
16.6% and 20.2% in P1 and P2, respectively, and absent
STATISTICAL ANALYSIS
in P3. OM decreased from 36.6% in P1 to 4.5% in P2 (P
Statistical analysis was performed with SPSS for Win- 0.01), and was absent in P3. Although not significant, the
dows, Version 8.0 (SPSS, Inc., Chicago, IL, USA), and ABD tended to increase over the periods (15.0%, 17.0%,
data have been expressed as mean  SD unless stated and 29.5%, respectively). Al overload was detected in
otherwise. For multiple comparisons of periods, Pearson all ABD patients in P1, 86.0% in P2, but only 20.0% in
Chi-Square and Exact Fisher tests were used. The P3 (P  0.05). Considering all bone biopsies, the Al
multivaried analysis was performed by logistic regression overload decreased from 42.0% in P1 to 20.0% in P2
for test risk factors. Values of P lower than 0.05 were (P 0.05), remaining stable in P3 (27.0%; NS). Concom-
considered statistically significant. itantly, the content of aluminum in the water for dialysis
showed 88.0% of samples in P2 with Al concentration
lower than 10 g/L, and in P3, 97.0% of samples belowRESULTS
2 g/L, showing an improvement in water quality. Data
Data from Brazil
from P1 were missing.
The prevalence of HP increased from 32.3% in P1 to
44.0% in P3 (P  0.05). This increase was also observed
DISCUSSIONin MBD (16.6% to 23.9%, P1 vs. P3, respectively, P 
0.05). On the other extreme of the ROD spectrum, OM This study describes the distribution of ROD pattern
in Brazil and Uruguay. One should be reminded thatdecreased significantly (32.9% to 11.7%, P1 vs. P3, P 
0.05; and 20.3% to 11.7%, P2 vs. P3, respectively, P  bone biopsies were performed in patients who were
symptomatic, or presented some clinical, radiologic, or0.01). The prevalence of ABD increased from 15.7% to
20.4%, P2 vs. P3, respectively, P  0.01 (Table 1). Al laboratory test abnormalities. Therefore, we cannot com-
pare our results with those obtained from studies per-overload was present in 61.3% of the patients in P1,
decreasing to 38.7% in P2 (P  0.0001), and remained formed in nonselected dialysis populations [9, 10]. We
observed a similar tendency in both ROD profiles (e.g.,stable in P3 (42.5%, P 0.05 vs. P1). Logistic regression
analysis showed that the occurrence of HP was corre- an increase in HP and a decrease in OM). The increasing
prevalence of HP could be related to longer survivallated with female gender (OR  1.27, P  0.05), age
less than 40 years (OR  1.37, P  0.01), black patients on dialysis, which is a key determinant of secondary
hyperparathyroidism [11]. In fact, in this study, one of(OR  1.64, P  0.05), time on dialysis more than four
years (OR  2.03, P  0.0001), and lack of Al overload the determinants of HP in Brazilian patients was longer
time on dialysis. These findings are in accordance with(OR 3.17, P 0.0001). Moreover, factors such as male
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race, black patients were prone to developing HP [14].
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